🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/10/2019 | 79,27 | 79,40 | 76,85 | 77,88 | -2,38% | 3,21% | 8.762.433 |
| 01/10/2019 | 80,32 | 80,73 | 79,71 | 79,78 | -0,68% | 1,26% | 7.050.001 |
| 30/09/2019 | 79,40 | 81,20 | 79,40 | 80,32 | +1,53% | 2,27% | 9.806.974 |
| 27/09/2019 | 80,04 | 80,14 | 78,80 | 79,11 | -1,16% | 1,68% | 7.827.093 |
| 26/09/2019 | 79,79 | 80,24 | 79,24 | 80,04 | +0,94% | 1,26% | 8.104.918 |
| 25/09/2019 | 79,65 | 80,18 | 79,15 | 79,29 | -0,60% | 1,29% | 7.290.936 |
| 24/09/2019 | 80,68 | 80,99 | 79,57 | 79,77 | -0,90% | 1,76% | 9.377.085 |
| 23/09/2019 | 81,02 | 81,32 | 80,48 | 80,50 | -0,94% | 1,04% | 8.909.572 |
| 20/09/2019 | 80,86 | 81,94 | 80,46 | 81,26 | +1,42% | 1,83% | 23.631.247 |
| 19/09/2019 | 79,22 | 80,44 | 79,08 | 80,12 | +1,14% | 1,71% | 6.922.774 |
| 18/09/2019 | 78,88 | 79,47 | 78,61 | 79,22 | +0,62% | 1,09% | 6.943.734 |
| 17/09/2019 | 78,37 | 79,68 | 78,37 | 78,73 | +0,59% | 1,67% | 7.375.405 |
| 16/09/2019 | 78,67 | 78,67 | 77,95 | 78,27 | -0,70% | 0,92% | 6.191.270 |
| 13/09/2019 | 79,17 | 79,74 | 78,36 | 78,83 | -0,84% | 1,75% | 7.521.496 |
| 12/09/2019 | 79,66 | 80,23 | 79,00 | 79,49 | +0,47% | 1,55% | 8.416.698 |
| 11/09/2019 | 78,11 | 79,30 | 77,88 | 79,12 | +1,51% | 1,82% | 10.602.197 |
| 10/09/2019 | 78,62 | 78,62 | 75,24 | 77,95 | -2,13% | 4,30% | 18.087.432 |
| 09/09/2019 | 82,54 | 82,56 | 79,12 | 79,65 | -3,58% | 4,16% | 12.040.786 |
| 06/09/2019 | 82,58 | 82,95 | 82,36 | 82,61 | +0,55% | 0,72% | 7.047.695 |
| 05/09/2019 | 82,67 | 82,69 | 81,58 | 82,16 | +0,06% | 1,34% | 7.524.954 |
| 04/09/2019 | 83,15 | 83,18 | 81,51 | 82,11 | -0,69% | 2,01% | 7.868.070 |
| 03/09/2019 | 82,29 | 83,02 | 82,10 | 82,68 | +0,21% | 1,12% | 6.695.882 |
| 30/08/2019 | 83,13 | 83,23 | 82,22 | 82,51 | -0,29% | 1,21% | 6.795.127 |
| 29/08/2019 | 83,08 | 83,35 | 82,23 | 82,75 | +0,28% | 1,34% | 6.321.012 |
| 28/08/2019 | 81,36 | 82,61 | 81,15 | 82,52 | +1,12% | 1,79% | 6.159.934 |
| 27/08/2019 | 82,46 | 82,94 | 81,54 | 81,60 | -0,42% | 1,70% | 6.527.049 |
| 26/08/2019 | 81,47 | 81,97 | 81,18 | 81,95 | +1,11% | 0,96% | 6.041.825 |
| 23/08/2019 | 82,27 | 82,96 | 80,61 | 81,05 | -2,05% | 2,85% | 10.608.694 |
| 22/08/2019 | 82,78 | 83,21 | 82,30 | 82,75 | -0,22% | 1,10% | 6.588.776 |
| 21/08/2019 | 82,34 | 83,25 | 82,19 | 82,93 | +1,47% | 1,30% | 6.486.072 |